Clinuvel Pharmaceuticals Limited (CLVLF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Clinuvel Pharmaceuticals Limited's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
14.42
Strong
WeakModerateStrong
P/B Ratio
2.16
Strong
WeakModerateStrong
Earnings Yield
6.96%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
15.02%
Strong
WeakModerateStrong
Operating Margin
48.13%
Strong
WeakModerateStrong
Net Profit Margin
38.07%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
7.76%
Moderate
WeakModerateStrong
Net Income Growth
1.50%
Weak
WeakModerateStrong
EPS Growth
-
No data
Efficiency & Liquidity
2025Current Ratio
9.66
Strong
WeakModerateStrong
Quick Ratio
9.34
Strong
WeakModerateStrong
Asset Turnover
0.35x
Weak
WeakModerateStrong
Inventory Turnover
1.80x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
7.85%
Strong
WeakModerateStrong
EV / Free Cash Flow
7.26x
Strong
WeakModerateStrong
Net Debt / EBITDA
-3.91x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.127
Strong
WeakModerateStrong
Return on Invested Capital
13.10%
Weak
WeakModerateStrong
Cash Conversion Cycle
249.62 days
Weak
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for CLVLF.
View Financial Statements